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Having recently finished watching the first season of Forbrydelsen (The Killing) I know 
something about Scandinavian knitwear. As the protagonist of this Danish TV thriller, Sarah 
Lund, doggedly solves a murder case, she is continuously huddling into a thick, cosy, 
snowflake sweater (there is even a website dedicated to this knitted garment). The traditional 
Scandinavian sweater is a useful image to have in mind when reading My Beautiful Genome: 
Exposing our Genetic Future, One Quirk at a Time, the most recent book by Danish science 
journalist Lone Frank, for it becomes a central metaphor within her argument:  
 
My genome is not a straitjacket but a soft sweater to fill and shape, to 
snuggle up and stretch out in. It is information I can work with and around, 
information that can grant me greater freedom to shape my life and my 
essence (p287). 
 
Like many Scandinavian thrillers, My Beautiful Genome (previously published in Danish as 
Mit Smukke Genome) tells the story of a quest for truth. In this case it is Lone Frank’s 
narrative of her search for information about her genetic past, present, and future. In many 
ways the straitjacket-sweater metaphor she uses is a clever one. The metaphor encapsulates 
the main message of the book - that genes are not our destiny but something we can “work 
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with” – while also referring to her search for traces of genetic associations that explain her 
own family history of depression. 
 
Lone Frank’s father often told her that while she had many “trophies on the shelves” (p6) in 
the genetics department, she did inherit some “bad” genes from both her parents in regards to 
depression. Describing herself as an “incurable melancholic” (p207), Frank details an 
“unbroken line” of depression in her family. Her great-grandfather killed himself, his 
daughter (her grandmother) almost had a lobotomy, her mother suffered from depression, her 
father was “manic-depressive” and attempted suicide twice, and her brother has depression 
too. Counting both sides, Frank declares, her family boasts three successful suicides. We 
learn much of this family medical history in the opening pages of the book, during the 
recounting of an interview conducted by a behavioural genetics researcher:  
 
‘Have any of your first-degree relatives had any mental health problems?’ 
‘Yes’ I say without hesitation. I’m asked to identify which ones. ‘All of 
them.’ [The researcher] mumbles to herself, leafing through her papers, 
confused. ‘All of them? Okay, okay. Where do we start?’ (p3). 
 
It is difficult to know where to start looking for answers in the world of psychiatric genetics. 
Although many psychiatric illnesses have been considered inheritable since classification, 
replicated research demonstrating significant genetic markers for diseases such as depression 
has been sparse. Just as straitjackets were used as a technology to cope with, and control, the 
unknown and feared aspects of mental illness, so too is genetic technology being used in an 
attempt to deal with the unknown. This remains a controversial area of research within 
psychiatry, and medicine more broadly. The recent move that some companies have made to 
advertise, or sell, genetic testing online directly to the public for diseases such as 
schizophrenia, bipolar disorder and autism, is contentious. 
 
While dipping her toes into the controversies of psychiatric genetics, Lone Frank focuses 
more doggedly on the many avenues available to her to find out about her own genetic 
predisposition to depression and other traits and illnesses. The lengths Frank goes to in this 
search are impressive. She undertakes genome sequencing and personality tests for a 
Copenhagen University Hospital research project examining the connection between specific 
genes and depression. She is tested by Icelandic genetic testing company deCODEme and 
mines her raw data for genetic associations found in the scientific literature. She has blood 
tests in order to take part in research by a pharmaceutical company looking for biomarkers 
for mental illness. Along the way Frank also: signs up for a free 23andMe account which 
means that she can vote for which diseases and conditions the genetic testing company should 
research; takes an ancestry test offered by an American firm wanting to recruit 
Scandinavians; has a genetic test for breast cancer (which requires pestering and convincing 
the clinical geneticist to run a full BRCA sequence); and finally a test for genetic romantic 
compatibility. Frank pulls others, including her brother, into being tested to aid her genetic 
search, while she is pulled into the romantic matching test by a work colleague, having her 
(Frank’s) boyfriend tested at the same time.  
 
The comparative findings of these tests are interesting, for they provide very different, and 
sometimes contrasting, pictures of Lone Frank’s psychiatric genetic makeup.  Mining her 
deCODEme raw data reveals an increased risk of depression, while the personality test tells 
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her that according to her neuroticism score she is “not particularly inclined towards 
depression” (p206). Later on her blood biomarkers put her “solidly in the group of depressed 
research subjects”, while the genetic analysis run by the Copenhagen University Hospital 
tells her that she has two short variants of the SERT gene (responsible for serotonin 
transportation), findings which show a particular vulnerability to depression in association 
with “unfortunate life circumstances” (p219). The test also shows that she has a double dose 
of the “worrier” variant of the COMT gene, variants of the BDNF gene which make her 
sensitive to stress and two copies of a less efficient MAOA variant which predisposes women 
to depression. The university research results seem to be the most reliable findings for Lone – 
she throws her pen on the table when hearing the news: “So my damned recurring 
depressions don’t just come from nowhere” (p219). She recognises the uncertainty of these 
findings but nonetheless considers herself a “pitiful loser in the genetic lottery” (p223). 
Interestingly, among all of these risks, inclinations, vulnerabilities and dispositions, the 
details of Lone Frank’s experience of actually living with depression is dealt with lightly. 
Similarly, only one visit to her doctor is discussed in the book, and that visit is made in order 
to have some blood taken for the pharmaceutical research, while a prescription for 
antidepressants is renewed on the side. What seems to be much more fascinating for the 
author is the information she can find about depression inscribed in her amino acids. 
 
The personal genetic testing narrative running throughout My Beautiful Genome is also a 
vehicle for Frank to discuss the current state of genetics.  This is not Frank’s first exercise in 
using her “self” as the central trope for exploring an area of science. Her previous book, The 
Neurotourist: Postcards From the Edge of Brain Science, examined the world of 
neuroscience while she underwent a series of cognitive tests, hormone tests and brain 
scanning. 
 
In My Beautiful Genome we meet the familiar characters from any genetic detective story: 
James Watson, with whom Frank talks about the importance of psychiatric genetics and the 
need to publish more genomes on the internet; Kári Stefánsson, deCODEme’s founder, who 
comes across as an annoyingly perfect genetic specimen; “elflike” and likeable Linda Avey, 
co-founder of 23andMe; and George Church from the Personal Genome Project. We also 
meet other less public characters on the genetic scene, such as the founders of Promethease (a 
free bioinformatics platform which allows users to learn more about their genotype), 
bloggers, epidemiologists and molecular scientists.  
 
Little is revealed in many of Frank’s interviews with famous characters beyond their public 
persona. Occasionally however an interview might reveal what is not made especially explicit 
in companies’ mission statements. When Frank comments to Linda Avey that 23andMe has 
been compared, not admiringly, to Facebook, Avey pats her on the arm and says that “‘The 
‘Facebook’ format is quite deliberate’, designed to encourage information sharing among 
users” (p121). Avey discusses one of the grand visions of 23andMe:  
 
We see ourselves as creating a sort of ecosystem of patients and users. 
People who stay with us on the website, who keep up with the developments 
and continue to enter in their data as they gradually get older. Can you see 
it? These groups – or cohorts – have built-in opportunities for conducting 
long-term studies that run for years. Studies that you cannot scrape together 
the money or the research subjects for today (p123). 
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This is an ambitious ethos which is embedded, without being explicit, in 23andMe webpages, 
as the company tries to garner greater involvement in their self-proclaimed “Research 
Revolution”, the democratic potential of which is not as straightforward as Avey would have 
it appear. 
 
Lone Frank is at her best when she is examining the process of genetic testing, as she 
describes her own experiences of being tested. There is a great account of what fun it was to 
receive the deCODEme swabbing material in the mail, scrape her cheek and send the sample 
back to Reykjavik for analysis. The fun dissipates when she receives her results, in a hotel 
room, alone. Frank opens a can of beer for company. She feels certain that the test is going to 
report a high risk of breast cancer and keeps her eyes closed, long after she has clicked on the 
results. Finding out that she has a lower than average risk, she feels “as if a very old, hissing 
pressure deep inside [her] body quickly seeps out and floats away” (p77). She pores over the 
rest of her results, well into the long Icelandic night, later digging into her raw data over a 
series of late evenings on sites like Promethease. The uncertainty, fear and waiting involved 
in genetic testing is captured well in an anxious series of paragraphs where Frank describes 
waiting for her breast cancer gene sequencing results and experiencing diarrhoea all 
weekend. 
 
Another strong aspect of the book is the science. As a science journalist, and being a biologist 
by training, Frank discusses the science well. When she uses jargon, she explains it. The book 
is very accessible, and would undoubtedly be of interest to those who want to learn more 
about genetic research. There is mention of many of the latest developments in genetic 
science: gene splicing, genetic engineering, the Human Genome Project, “snips” (or SNPs - 
single nucleotide polymorphisms), genomewide association studies and direct-to-consumer 
genetic testing (all in chapter one); paternity tests, ancestry tests, the ambitious genographic 
project (chapter two); 23andMe’s Research Revolution, “genome bloggers” and others 
publishing their genetic profiles on the internet (chapter four); eugenics, schizophrenia twin 
studies, behavioural genetics, genetics x environment research, the connection between 
genetics and brain imaging (chapter five); personality research (chapter six); epigenetics 
(chapter seven); and finally genetic dating services, pre-implantation diagnostics and designer 
babies (chapter eight).  
 
Just as readable as the ‘genetics 101’ sections are Frank’s discussions of genetic research. 
Some parts of My Beautiful Genome read like a bibliography that has come to life; research 
from genomewide association studies to metanalyses published in American Journal of 
Human Genetics, Nature and Molecular Psychiatry become interesting and personalised. She 
uses clothing and interior decoration to give personality to the clinicians and scientists who 
have written these articles, picturing them in their offices with grey leather Arne Jacobsen 
chairs or in a cosy suburban kitchen with freshly baked brownies on the table.  
 
Alas, if only she breathed the same kind of life into her biography as she does her 
bibliography. While Frank does offer us threads of genealogy - nostalgic moments with 
grandparents, sepia-toned photographs, memories of ancestors’ illnesses and times with her 
father – her book is missing a richer sense of her own personal history, especially in relation 
to her experience of depression. What was it like to grow up in a family of “depressives” for 
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example? What was she like as a teenager, a young adult, a science PhD? How has living in 
Denmark shaped her health and healthcare experiences?  Frank claims that she wants to 
understand how the “accidents of biology” have shaped her life, her opportunities, her 
limitations, yet provides the reader with only very few glimpses into that life, those 
opportunities and limitations. While she does not claim to be writing an autobiography, the 
absence of her personal history nonetheless works to privilege a genetic view of her life story. 
 
It is the few enticing glimpses into her biography which we are granted - her ability to deal 
with newspaper deadlines, a shoplifting incident - which make me want to know more, as I 
search for a less atomised understanding of this interesting woman and a more complex 
understanding of how genetics interplay with other aspects of her life. My Beautiful Genome 
is personal, but mostly at the molecular level. Frank’s story is so biological. When she talks 
about her interest in the human being as an organism, she does not refer here to an individual 
living in a rich social environment as an anthropologist or geographer might, but rather to the 
“microscopic processes unfolding” within us (p5). Even the “godfather of genetics”, James 
Watson, admits in an interview with Frank that genetics are not central to his understanding 
of self. In response to her question about how knowing his genome has affected him, he 
replies “to be honest, I don’t think much about it” (p17). 
 
Anthropological and sociological research has shown that individuals often weave genetic 
information into their own pre-existing stories of relatedness and risk. Kerr and colleagues 
found in their research that the public had an experientially based knowledge of genetics, 
threading genetic information into everyday understanding of kinship2. In their study of 
Alzheimer’s disease genetics, Lock and her colleagues found that genetic knowledge rarely 
usurped other forms of understanding, but was rather nested into previously held ideas3. Cox 
and McKellin suggest that the relevance of genetic risk to individuals is fluid and contingent, 
with information given higher relevance at certain critical junctures and at other times much 
less important4. Genetic information does not stand apart from other notions of inheritance 
and biography but rather becomes embedded into the complex ways we understand 
connections of relatedness and perceptions of risk.  
 
Lone Frank is a science journalist, and good at explaining scientific matters for a broad 
audience, but less good at critically examining the “genetic supermarket” (p34) that she has 
entered. This is an aspect of the story that would be more prevalent in an anthropological or 
sociological account of genetic testing. Frank rarely criticises the commercial developments 
she documents and engages with, instead attempting neutrality, relying on others’ critiques 
and letting her characters to speak in a way which does not implicate themselves.  
 
There is also throughout the book an uncritical undercurrent of celebration of developments 
in genetic testing. Frank adopts industry words like “revolution” (p8), highlighting what she 
views as democratic (“genetic tests can be bought in supermarkets and pharmacies, tens of 
thousands of people around the world are getting acquainted with their genetic information 
by using it” (p286)), progressive (“in the next ten years, all newborns will routinely have 
their genome mapped” (p8)) and utopian (“presently, we’re in the Wild West of personal 
genetic services – young, exciting, and full of golden opportunities” (p34)). According to My 
Beautiful Genome technological advance is inevitable, so we just need to engage with these 
technologies and enjoy the ride. 
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This technological drive may in fact be at the heart of Lone Frank’s quest, which could be 
seen as a search not only for genetic truth, but also to understand herself through new 
technologies and gadgets, whether they are related to genetics or to neuroscience. During a 
break in proceedings at a Human Genetics conference, Frank describes “standing in a corner 
feeling embarrassed” by her “passé SNP profile from deCODEme. It almost feels like I’m 
carrying around a chunky first-generation brick of a Nokia, while everyone else is watching 
videos on their iPhone 4s” (p138). Instead she wants to be part of the “in-crowd” (p139).  
How much of this trendiness drives other consumers of direct-to-consumer genetic testing? In 
their study of early adopters of direct-to-consumer genetic testing (half of whom, like Frank, 
worked in a field related to science), Michelle McGowan and colleagues showed that many 
of their participants viewed themselves as early adopters of new technologies more generally, 
and that this was the reason they wanted to try genetic testing5. My Beautiful Genome is 
situated very much within this context of technoscience/medical consumerism, with Lone 
Frank becoming a poster girl for consumer genomics. 
 
Frank does recognise that not everyone may want to be part of this particular in-crowd. She 
wonders during a conference break, rather patronisingly, whether discussion about 
microbiomics and next generation sequencing would interest the girl serving the croissants. 
Nonetheless Frank writes with an underlying assumption that her audience will be those who 
also want to be in the in-crowd, or at the very least are interested in developments in genetic 
science.   
 
Although My Beautiful Genome does not sit neatly within the illness narrative genre (indeed, 
as previously discussed, her own experience of depression is barely mentioned), it could 
certainly be read as a quest narrative6. Quest narratives have been criticised for being too 
neat, detailing clean transformation through discovery7. While Frank may engage in some 
wrapping-up towards the end of her book - concluding that she has terrible genes but can 
view these positively and make changes in her life in order to optimise her chances - her 
narrative doesn’t suffer wholly from linear completeness. Rather, her story shows that 
psychiatric genetics, behaviour genetics and genetic testing are all imbued with some degree 
of uncertainty. 
 
Perhaps the book could be considered part of another evolving sub-genre in literature, which 
may sit alongside the illness narratives, a kind of pre-illness narrative mixing autobiography 
with science journalism; a genre I would describe as auto-biology. Auto-biology is a term 
which possibly captures personal narratives, such as Frank’s, which are all biology; stories 
told from a “molecular gaze”8 where one’s story centres around bundles of neurons or 
ribonucleic acid and the array of technologies tied up with understanding the body at this 
level. There is room for further scholarly analysis of these narratives, and the ways in which 
they shed light on how people think about science, as well as disease categories and other 
aspects of health and illness. 
 
Having a background in medical science I can certainly see the appeal of this kind of 
exploring and writing.  Yet I also yearn for more biography with my biology. I want to know 
how genetics becomes stitched into other ways of knowing and experiencing the world. In 
many ways it is ironic that Frank uses the loose sweater as a metaphor, one which could be 
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seen to refer to epigenetics and the way the environment shapes genetic expression. Although 
in using this metaphor Frank is suggesting that she challenges a reductionist view in genetics, 
the material she presents and the assumptions she makes about the results that she receives 
suggest that she does indeed privilege genetics (p901), at least in this account. Her own 
environment so seldom appears in the story that her narrative reiterates new forms of genetic 
determinism, or “genetic enlightenment”, which arguably predominate in the psychiatric 
genetic literature, where the role of the environment is merely rhetoric9. 
 
This does not mean that we need to discard the sweater metaphor completely however. A 
typical Scandinavian sweater, such as that worn by Sarah Lund, often has two different 
coloured yarns from different coloured sheep: one for the pattern, such as the snowflake, and 
another for the background. When knitting this kind of sweater the contrast yarn is pulled 
forward occasionally, to make the shards of the snowflake, but is otherwise kept behind the 
knitting. I like to think of genetic knowledge as the contrasting coloured wool which is 
knitted into an individual’s sense of self-making, at particular moments, or junctures, in their 
lives, but which is generally kept in the background at many others. My Beautiful Genome is 
a well-written, readable, often witty narrative of a lone, intelligent, driven, technologically 
and genetically curious individual’s journey into the world of personal genomics. I may be 
picky, or even nosey, but I would have liked a few more yarns to make the story just that 
little bit more personal. 
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